Marion Doull’s research while affiliated with Public Health Agency of Canada and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (13)


Ligne directrice sur le dépistage de l’adénocarcinome œsophagien chez les patients atteints de reflux gastro-œsophagien chronique
  • Article

November 2020

·

7 Reads

Canadian Medical Association Journal

Stéphane Groulx

·

Heather Limburg

·

Marion Doull

·

[...]

·

Brett Thombs


Fig. 1 Analytic framework
Fig. 2 PRISMA flowchart-summary of evidence search for the benefits and harms of screening and treatment for thyroid dysfunction (KQ1-4)
Fig. 3 PRISMA flowchart-summary of evidence search for patient's preferences and values towards screening for thyroid dysfunction (KQ5)
Summary of differences between groups on measures of mental well-being
Summary of differences between groups on measures of general well-being

+6

Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review
  • Literature Review
  • Full-text available

November 2019

·

139 Reads

·

17 Citations

Systematic Reviews

Background: This systematic review was conducted to inform the Canadian Task Force on Preventive Health Care recommendations on screening for thyroid dysfunction (TD). The review sought to answer key questions on the benefits and harms of screening for TD, patients' values and preferences for screening, and the benefits and harms of treating screen-detected TD. Methods: This review followed Canadian Task Force on Preventive Health Care methods, which include the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. The search strategy used for benefits and harms of screening and treatment was an update to the 2014 review by the US Preventive Services Task Force and searched MEDLINE and the Cochrane Library. MEDLINE, Embase, ProQuest Public Health, and SCOPUS were searched for patients' values and preferences for screening. Outcomes of interest included all-cause mortality, deaths due to cardiovascular diseases, fatal and non-fatal cardiovascular events, atrial fibrillation, fractures, quality of life, cognitive function, and harms due to TD treatment. Two reviewers independently screened abstracts and full texts according to pre-determined inclusion criteria and assessed the risk of bias for each study included. Strength and quality of the evidence was assessed for each outcome. A narrative synthesis was conducted due to heterogeneity of the included studies. Results: No studies were found on screening for TD, treatment of subclinical hyperthyroidism, or patients' values and preferences for screening for TD. Twenty-two studies (from 24 publications) on the treatment of TD in patients with screen-detected subclinical hypothyroidism were included. Results from the included randomized controlled trials suggested no benefit of treatment for subclinical hypothyroidism for the large majority of outcomes. We found very low-quality evidence (from two cohort studies) for a small reduction in all-cause mortality among adults < 65 or 40-70 years who were treated for TD compared to those who were not. Conclusions: This review found moderate to very low-quality evidence on the benefits and harms of treatment for subclinical hypothyroidism, with most of the evidence showing no benefit of treatment.

Download



Fig. 1 Analytical framework
Table 1 Eligibility criteria using PICOTS for Key Questions 1 and 2: Effectiveness and comparative effectiveness of screening approaches
Table 2 Eligibility criteria using PICOTS for Key Question 3: Outcome valuation
Screening for chlamydia and/or gonorrhea in primary health care: Protocol for systematic review

December 2018

·

238 Reads

·

11 Citations

Systematic Reviews

Background: Chlamydia trachomatis and Neisseria gonorrhoeae are the most commonly reported sexually transmitted infections in Canada. Existing national guidance on screening for these infections was not based on a systematic review, and recommendations as well as implementation considerations (e.g., population groups, testing and case management) should be explicit and reflect the quality of evidence. The aim of this systematic review is to synthesize research on screening for these infections in sexually active individuals within primary care. We will also review evidence on how people weigh the relative importance of the potential outcomes from screening, rated as most important by the Canadian Task Force on Preventive Health Care (CTFPHC) with input from patients and stakeholders. Methods: We have developed a peer-reviewed strategy to comprehensively search MEDLINE, Embase, Cochrane Library, CINAHL, and PsycINFO for English and French literature published 1996 onwards. We will also search trial registries and conference proceedings, and mine references lists. Screening, study selection, risk of bias assessments, and quality of findings across studies (for each outcome) will be independently undertaken by two reviewers with consensus for final decisions. Data extraction will be conducted by one reviewer and checked by another for accuracy and completeness. The CTFPHC and content experts will provide input for decisions on study design (i.e., when and whether to include uncontrolled studies for screening effectiveness) and for interpretation of the findings. Discussion: The results section of the review will include a description of all studies, results of all analyses, including planned subgroup and sensitivity analyses, and evidence profiles and summary of findings tables incorporating assessment based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) methods to communicate our confidence in the estimates of effect. We will compare our findings to others and discuss limitations of the review and available literature. The findings will be used by the CTFPHC—supplemented by consultations with patients and stakeholders and from other sources on issues of feasibility, acceptability, costs/resources, and equity―to inform recommendations on screening to support primary health care providers in delivering preventive care.






Citations (5)


... Patients with alarm symptoms such as dysphagia, odynophagia, anemia, weight loss, recurrent vomiting, loss of appetite, or GI bleeding should be evaluated. Risk factors for EAC include male sex, older age, White race, Barrett esophagus, nocturnal reflux, abdominal obesity, and tobacco use (23,24). Risk factors for ESCC include low socioeconomic status, tobacco or alcohol use, consumption of hot or pickled foods, low consumption of fruits and vegetables, and radiation exposure (25). ...

Reference:

A Canadian algorithm for upper gastrointestinal cancer management
Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease
  • Citing Article
  • July 2020

Canadian Medical Association Journal

... OGTT is the standard diagnostic tool for gestational diabetes and is vital for the health of both the mother and the developing fetus [56]. f ) Thyroid stimulating hormone (TSH), free serum triiodothyronine (T3), and free serum thyroxine (T4) for diagnosing thyroid dysfunction Measurement of thyroid function tests, including TSH, free T3, and free T4, is essential for diagnosing thyroid dysfunction [57]. Our software allows the estimation and plotting of the sampling, measurement, and combined uncertainty of Bayesian diagnostic measures and their confidence intervals. ...

Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Systematic Reviews

... According to epidemiological studies, pathological leucorrhoea could affect women of any age, including young girls, pregnant women in good health, and older individuals who were unaware of their socioeconomic situation, educational background, and cultural background. However, women with low levels of education and socioeconomic status were more likely to experience this situation (Tanwar et al., 2022;Pillay et al., 2018;Smith, 2021). ...

Screening for chlamydia and/or gonorrhea in primary health care: Protocol for systematic review

Systematic Reviews

... The cutoff of 50 years was chosen given that routine cancer screening is generally recommended starting at age 50 years for individuals at standard risk of common types of cancers (e.g., breast cancer and colon cancer) with the exception of those patients with a family history or cancer and cervical cancer screening in women. [12][13][14] Male and female patients were also separated into 2 categories to allow respondents to select sex-specific investigations and because cancer screening guidelines differ between sexes. [12][13][14] We also inquired about the use or knowledge of specific guidelines to help inform decision making. ...

Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer
  • Citing Article
  • December 2018

Canadian Medical Association Journal

... 8,9 Moreover, clinical guidelines increasingly advocate for urine cultures in the management of symptomatic bacteriuria in pregnant women. 10,11 However, accurate interpretation of urine cultures is complicated by the possibility of contamination stemming from various factors, including improper sample collection and storage techniques. 12,13 Misidentification of causative organisms due to culture contamination leads to unnecessary healthcare resource utilisation and ineffective treatment through inappropriate antibiotic prescriptions, exacerbating global concerns regarding antimicrobial resistance. ...

Recommendations on screening for asymptomatic bacteriuria in pregnancy
  • Citing Article
  • July 2018

Canadian Medical Association Journal